Presented
by

Presented by Oxford Global

Member Login
|
Become a Member

All Discovery Content

Bringing you the latest research in Drug Discovery In New Modalities, Integration Of DEL, Covalent Inhibitors, Protein Degradation Technologies, Computational Drug Design & Automation Strategies and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Discussion Group Report
AlphaFold and Drug Design: Has AI Solved Biology’s ‘Grand Challenge?’
Govinda Bhisetti, Principal Investigator and Head of Computational Chemistry at Biogen, leads a discussion group on what the revolutionary machine learning technology means for drug design.
By Tom Cohen |
21 April 2022
Computational Drug Design & AI
Commentary
Merck KGaA: Accelerating Drug Discovery with Automation and Artificial Intelligence
There are innumerable possible compounds in Merck KGaA’s virtual library, so finding drug candidates is only possible with the help of computational methods.
By Tom Cohen |
23 March 2022
Computational Drug Design & AI
Insight Article
Artificial Intelligence for Drug Design and Discovery
Artificial intelligence and machine learning could be an invention comparable to electricity, so what does the future hold for its use in drug discovery?
By Tom Cohen |
16 March 2022
Computational Drug Design & AI
Video Content
Webinar
Novel Strategies To Accelerate Discovery Of Translatable Therapeutic Targets
Presented by Zoltan Spiro, Target Discovery Lead, Turbine AI | Steve Harrison, CSO, Engine Bio | Quin Wills, CSO, Ochre Bio | Dave Madge, Vice President, Wuxi Apptec
13 October 2021
Computational Drug Design & AI
Written Q&A
Functional Magnetic Resonance Imaging Within R&D
Pradeep Nathan, Vice President Clinical Development & Head of Experimental Medicine (Neuroscience), Sosei Heptares, Professor of Neuroscience, Monash University and Affiliated Lecturer, University of Cambridge
11 June 2019
Computational Drug Design & AI
Written Q&A
AI and Superhuman Drug Discovery
Willem Van Hoorn, Chief Decision Scientist, Exscientia
11 June 2019
Computational Drug Design & AI
Written Q&A
The Future of Machine Learning and AI within Drug Discovery
Brandon Allgood, CTO and cofounder, Numerate Inc.
11 June 2019
Computational Drug Design & AI
Video Content
Video Q&A
Brandon Allgood Interview | Drug Discovery Series 2019
Brandon Allgood, CTO & Co-Founder at Numerate, Inc, responds to questions from Oxford Global at our R&D Series 2019 in Berlin.
11 June 2019
Computational Drug Design & AI
Video Content
Webinar
Application Computer-Guided Discovery of Bioactive Natural Products
Webinar on 'Application Computer-Guided Discovery of Bioactive Natural Products' hosted by Johannes Kirchmair, Professor of Applied Bioinformatics, University of Hamburg
04 March 2019
Computational Drug Design & AI
Video Content
Webinar
Application Computer-Guided Discovery of Bioactive Natural Products
Johannes Kirchmair, Professor of Applied Bioinformatics, University of Hamburg
07 June 2018
Computational Drug Design & AI

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login